Seven Eight Capital’s NEVRO CORP. NVRO Stock Holding History

Seven Eight Capital’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,800	Closed	-$808K	–	667
2020 Q3	$808K	Buy	+5,800	New	+$775K	0.17%	228
2020 Q1	–	Sell	-19,829	Closed	-$2.33M	–	759
2019 Q4	$2.33M	Sell	19,829 -773	-4%	-$76.6K	0.12%	255
2019 Q3	$1.77M	Buy	+20,602	New	+$1.56M	0.09%	322
2019 Q2	–	Sell	-30,416	Closed	-$1.9M	–	771
2019 Q1	$1.9M	Sell	30,416 -21,600	-42%	-$1.02M	0.1%	254
2018 Q4	$2.02M	Buy	52,016 +18,598	+56%	+$827K	0.11%	233
2018 Q3	$1.91M	Buy	+33,418	New	+$2.09M	0.12%	253
2017 Q3	–	Sell	-3,618	Closed	-$269K	–	653
2017 Q2	$269K	Buy	+3,618	New	+$290K	0.04%	366
2016 Q3	–	Sell	-900	Closed	-$66K	–	582
2016 Q2	$66K	Sell	900 -2,900	-76%	-$197K	0.02%	431
2016 Q1	$214K	Buy	+3,800	New	+$224K	0.09%	291

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Seven Eight Capital's NVRO Position: Q4 2020 in Review

Seven Eight Capital sold out of NEVRO CORP. (NVRO) in Q4 2020, closing a stake of 5,800 shares — an estimated $808K sold.

Seven Eight Capital first reported a position in NVRO in Q1 2016 and held it in 9 quarters. The position peaked at $2.33M in Q4 2019. 226 funds tracked by Wall St. Rank hold NVRO as of Q4 2020.

Seven Eight Capital reported no remaining NEVRO CORP. position as of Q4 2020 after selling out during the quarter.
Seven Eight Capital sold 5,800 NEVRO CORP. shares in Q4 2020, an estimated $808K.
Seven Eight Capital first reported a position in NEVRO CORP. in Q1 2016 and held it in 9 quarters.
Seven Eight Capital's NEVRO CORP. position peaked at $2.33M in Q4 2019.
226 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2020.

Based on Seven Eight Capital's 13F filing for Q4 2020, filed 9 Feb 2021.